New Zealand markets closed

Biora Therapeutics, Inc. (PROG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8845-0.0318 (-3.47%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.9163
Open0.9005
Bid0.0000 x 900
Ask0.0000 x 1400
Day's range0.8400 - 0.9200
52-week range0.6301 - 6.2000
Volume2,779,613
Avg. volume6,366,301
Market cap162.924M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.5730
Earnings date10 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.00
  • GlobeNewswire

    Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform

    Marks 29 Patents Worldwide Directed to Biora’s Device Localization TechnologySAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced a new patent related to its Drug Delivery System (DDS) platform under development. The USPTO has issued U.S. Patent No. 10,835,152 entitled, “Electromechanical pill device with localization capabilities” and allowed U.S. Application No. 15/940,407 entitled, “Localizat

  • GlobeNewswire

    Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference

    SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the Company’s management team will be presenting a corporate overview and participating in one-on-one meetings, upon request, with conference attendees at the upcoming H.C. Wainwright Global Investment Conference, which is taking place both virtually and in-person at the Fontainebleau Hotel in Miami, Florida, May 23 to 26, 2022. H.C. Wain

  • GlobeNewswire

    Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

    Completed transformation with the launch of Biora Therapeutics to reflect the company’s focus on oral therapeutic solutions Successfully transferred its single-molecule detection platform with launch of Enumera Molecular Strengthened therapeutics capability and leadership with addition of Paul Shabram and opening of operations lab space Management will host conference call and webcast today at 4:30 p.m. Eastern / 1:30 p.m. Pacific SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, I